Guest guest Posted March 15, 2002 Report Share Posted March 15, 2002 SLE / A Promising Future Researchers are investigating more targeted SLE therapies that can avoid the potentially dangerous side effects associated with current treatments. Medications currently being investigated include dehydroepiandresterone (DHEA), a mild male hormone; bromocriptine, which reduces prolatin levels (a tituitary hormone that is elevated in SLE); LJP 394 and leflunomide (Arava), which zero in on particular aspects of the immune system ( such as the antibodies responsible for lupus kidney disease or the immune cells responsible for inflammation); genetically cloned (monoclonal) antibodies to immune system proteins, which are though to play a role in triggering SLE; and transplantation of blood-forming stem cells ( which produce red & white blood cells and platelets) in conjunction with cyclophosphamide (Cytoxan)m a sttitixuc dryg, Ut biw aooears tgat sgirt-tern gufg-dise cyclophosphamide therapy can be effective without stem cell transportation. From: The Hopkins Medical Letter / April, 2002 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.